CURRENT PHARMACEUTICAL REGULATIONS OF UNITED KINGDOM: POST BREXIT

Authors

  • KAMARAJ R
  • PANGA YAMINI

DOI:

https://doi.org/10.47750/pnr.2022.13.S06.455

Keywords:

Medical and Healthcare Regulatory Agency, United Kingdom, Yellow Card, Active Substance Master File, European Commission.

Abstract

The Medical and Healthcare Regulatory Agency is a Healthcare agency which was established in the United Kingdom and regulates drugs and medical equipment. The guidelines for marketing drugs and medical equipment are under European Medicines Agency. The United Kingdom officially left the European Union on 31st January 2020. So, the Medical and Healthcare Regulatory Agency was started and the guidelines are given by them. The yellow card scheme was established and it collects the adverse effects data of medicals from the patients directly online on the Medical and Healthcare Regulatory Agency website which helps in drug development and new drug investigation. The licence for drug marketing was done through the Medical and Healthcare Regulatory Agency website. By submitting the documents in electronic Common Technical Document format. It will take around 12-18 months. There are some new marketing authorisation assessment routes Medical and Healthcare Regulatory Agency has published.

Downloads

Published

2022-10-21

Issue

Section

Articles

How to Cite

CURRENT PHARMACEUTICAL REGULATIONS OF UNITED KINGDOM: POST BREXIT. (2022). Journal of Pharmaceutical Negative Results, 3406-3415. https://doi.org/10.47750/pnr.2022.13.S06.455